TELA Bio Inc
(NAS:TELA)
$
3.03
0 (0%)
Market Cap: 119.35 Mil
Enterprise Value: 143.57 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 53/100 TELA Bio Inc at JMP Securities Life Sciences Conference Transcript
Jun 16, 2022 / 01:30PM GMT
Release Date Price:
$5.99
(+1.18%)
David Turkaly
JMP Securities LLC - Analyst
This is the one we've been waiting for.
Tony Koblish
TELA Bio, Inc. - Co-Founder, President & CEO
All right, David. Appreciate it.
Questions & Answers
David Turkaly
JMP Securities LLC - Analyst
Yes, this is TELA Bio, one of our top picks. We have Tony and Roberto from the Company here with me. Obviously the last couple years have been challenging for a number of reasons, but I feel like you guys have managed to grow really well through it. So, I guess talk a little bit about what's gone on hernia with COVID and now beyond -- hopefully, beyond sort of what you're seeing from a volume or rebound in hernia procedures?
Tony Koblish
TELA Bio, Inc. - Co-Founder, President & CEO
Yes. So, we likely were the last MedTech company, one of the last MedTech companies to go public before COVID hit. And then we were implementing our first big GPO contract with HealthTrust in March of 2020 just as COVID hit. And what we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot